TY - JOUR
T1 - Preferences for implementation of HIV pre-exposure prophylaxis (PrEP)
T2 - Results from a survey of primary care providers
AU - Edelman, E. Jennifer
AU - Moore, Brent A.
AU - Calabrese, Sarah K.
AU - Berkenblit, Gail
AU - Cunningham, Chinazo O.
AU - Ogbuagu, Onyema
AU - Patel, Viraj V.
AU - Phillips, Karran A.
AU - Tetrault, Jeanette M.
AU - Shah, Minesh
AU - Blackstock, Oni
N1 - Funding Information:
This work was generously supported by Yale Center for Clinical Investigation ( UL1 TR000142 ). EJ Edelman was supported as a Yale Drug Abuse, Addiction and HIV Research Scholars (DAHRS) Program during the writing of this manuscript ( K12DA033312-03 ). BA Moore was supported by R01 DA034678 . SK Calabrese was supported by K01-MH103080 . O Blackstock was supported by K23MH102129-03 , VV Patel was supported by K23MH102118 . KA Phillips was supported by the NIDA- IRP , NIH. CO Cunningham was supported by K24DA036955 , R25DA023021 .These funding sources had no role in the study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.
Funding Information:
We would like to acknowledge the efforts of Dr. David Fiellin in informing the development of the PCP Survey and guidance in manuscript preparation. The research presented in this paper is that of the authors and does not reflect the official policy of the NIH. This work was generously supported by Yale Center for Clinical Investigation (UL1 TR000142). EJ Edelman was supported as a Yale Drug Abuse, Addiction and HIV Research Scholars (DAHRS) Program during the writing of this manuscript (K12DA033312-03). BA Moore was supported by R01 DA034678. SK Calabrese was supported by K01-MH103080. O Blackstock was supported by K23MH102129-03, VV Patel was supported by K23MH102118. KA Phillips was supported by the NIDA-IRP, NIH. CO Cunningham was supported by K24DA036955, R25DA023021.These funding sources had no role in the study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication. An earlier version of this work was presented as a poster presentation at the Society of General Internal Medicine 29th National Annual Meeting on May 13, 2016 in Hollywood, Florida.
Publisher Copyright:
© 2019 The Authors
PY - 2020/3
Y1 - 2020/3
N2 - Primary care physicians (PCPs) are critical for promoting HIV prevention by prescribing pre-exposure prophylaxis (PrEP). Yet, there are limited data regarding PCP's preferred approaches for PrEP implementation. In 2015, we conducted an online survey of PCPs’ PrEP prescribing and implementation. Participants were general internists recruited from a national professional organization. We examined provider and practice characteristics and perceived implementation barriers and facilitators associated with preferred models for PrEP implementation. Among 240 participants, the majority (85%) favored integrating PrEP into primary care, either by training all providers (“all trained”) (42%) or having an onsite PrEP specialist (“on-site specialist”) (43%). Only 15% preferred referring patients out of the practice to a specialist (“refer out”). Compared to those who preferred to “refer out,” participants who preferred the “all trained” model were more likely to spend most of their time delivering direct patient care and to practice in the Northeast. Compared to participants who preferred the “refer out” or on-site specialist” models, PCPs preferring the all trained model were less likely to perceive lack of clinic PrEP guidelines/protocols as a barrier to PrEP. Most PCPs favored integrating PrEP into primary care by either training all providers or having an on-site specialist. Time devoted to clinical care and geography may influence preferences for PrEP implementation. Establishing clinic-specific PrEP protocols may promote on-site PrEP implementation. Future studies should focus on evaluating the effectiveness of different PrEP implementation models on PrEP delivery.
AB - Primary care physicians (PCPs) are critical for promoting HIV prevention by prescribing pre-exposure prophylaxis (PrEP). Yet, there are limited data regarding PCP's preferred approaches for PrEP implementation. In 2015, we conducted an online survey of PCPs’ PrEP prescribing and implementation. Participants were general internists recruited from a national professional organization. We examined provider and practice characteristics and perceived implementation barriers and facilitators associated with preferred models for PrEP implementation. Among 240 participants, the majority (85%) favored integrating PrEP into primary care, either by training all providers (“all trained”) (42%) or having an onsite PrEP specialist (“on-site specialist”) (43%). Only 15% preferred referring patients out of the practice to a specialist (“refer out”). Compared to those who preferred to “refer out,” participants who preferred the “all trained” model were more likely to spend most of their time delivering direct patient care and to practice in the Northeast. Compared to participants who preferred the “refer out” or on-site specialist” models, PCPs preferring the all trained model were less likely to perceive lack of clinic PrEP guidelines/protocols as a barrier to PrEP. Most PCPs favored integrating PrEP into primary care by either training all providers or having an on-site specialist. Time devoted to clinical care and geography may influence preferences for PrEP implementation. Establishing clinic-specific PrEP protocols may promote on-site PrEP implementation. Future studies should focus on evaluating the effectiveness of different PrEP implementation models on PrEP delivery.
KW - HIV prevention
KW - Implementation
KW - Pre-exposure prophylaxis
KW - Primary care physicians
UR - http://www.scopus.com/inward/record.url?scp=85076456956&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85076456956&partnerID=8YFLogxK
U2 - 10.1016/j.pmedr.2019.101012
DO - 10.1016/j.pmedr.2019.101012
M3 - Article
C2 - 31890474
AN - SCOPUS:85076456956
VL - 17
JO - Preventive Medicine Reports
JF - Preventive Medicine Reports
SN - 2211-3355
M1 - 101012
ER -